Krystelis-Phesi Partnership Announcement

Krystelis-Phesi Partnership Announcement

Exciting Partnership Announcement: Krystelis & Phesi join forces to support diversity, equity, and inclusion in clinical trials!

We are thrilled to announce our partnership with Phesi to launch a Diversity, Equity, and Inclusion (DEI) Data Service. Together, we’re transforming clinical trials, enhancing diversity, and addressing diversity gaps in clinical trials, ensuring safer and more effective treatments.

Key Benefits for Sponsors:
✅ Enhanced Diversity: From planning to execution, sponsors can improve representation in clinical trials.
✅ Cost Savings: Avoid costly protocol amendments, potentially saving millions.
✅ Regulatory Compliance: Meet stringent global DEI rules, including FDA requirements.
✅ Added Value: Leveraging Krystelis’ medical writing capabilities for more efficient, transparent, and compliant trials.

This collaboration is a significant step towards more equitable and efficient clinical development. We’re committed to shaping a future where healthcare innovation benefits everyone. 

Read more about it here:

Diversity, Equity, and Inclusion Data Service for clinical development  – Drug Discovery World (DDW)

Phesi and Krystelis collaborate to launch new Diversity, Equity, and Inclusion Data Service for clinical development –